Source-grounded facts extracted from Cibus, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Laurent Arthaud resigned as Director at Cibus, Inc..
“Michael A. Carr, Yves J. Ribeill, Laurent Arthaud, Philippe Dumont, Jonathan B. Fassberg, Anna Ewa Kozicz-Stankiewicz, Kimberly Nelson and Christopher J. Neugent resigned from the Board and committees of the Board on which they respectively served”
Yves J. Ribeill resigned as Director at Cibus, Inc..
“Michael A. Carr, Yves J. Ribeill, Laurent Arthaud, Philippe Dumont, Jonathan B. Fassberg, Anna Ewa Kozicz-Stankiewicz, Kimberly Nelson and Christopher J. Neugent resigned from the Board and committees of the Board on which they respectively served”
Michael A. Carr resigned as Director at Cibus, Inc..
“Michael A. Carr, Yves J. Ribeill, Laurent Arthaud, Philippe Dumont, Jonathan B. Fassberg, Anna Ewa Kozicz-Stankiewicz, Kimberly Nelson and Christopher J. Neugent resigned from the Board and committees of the Board on which they respectively served”
Cibus, Inc. shareholders approved non-binding advisory vote on the frequency of future Say-on-Pay advisory votes at the 2023-05-02 meeting.
“Based on the final results of the stockholder vote at the Company’s 2023 Annual Meeting of Stockholders held on May 2, 2023, including stockholders’ non-binding recommendation to hold future Say-on-Pay advisory votes every one year, the board of directors of the Company (the “ Board ”) has determined that future Say-on-Pay advisory votes will be conducted every one year.”
Cibus, Inc. amended revolving credit of increased to $5,000,000 in the aggregate with Cibus Global LLC.
“(“Calyxt” or the “Company”) on January 17, 2023 (the “Merger 8-K”), pursuant to the terms of the Merger Agreement (as defined in the Merger 8-K), beginning on March 15, 2023, Calyxt could request, and Cibus Global LLC (“Cibus”) has agreed to provide, an unsecured, interest-free revolving line of credit of up to $3,000,000 in cash, which amount may be increased as described in the Merger 8-K (the “Interim Funding”).”
Cibus, Inc. shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2023 at the 2023-05-02 meeting.
“4. To ratify the appointment by the Audit Committee of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2023.”
Cibus, Inc. shareholders approved Advisory vote on the frequency of future votes to approve the compensation of named executive officers at the 2023-05-02 meeting.
“3. To approve, on an advisory basis, the frequency of future votes to approve the compensation of the Company's named executive officers.”
Cibus, Inc. shareholders approved Advisory vote to approve the compensation of the Company's named executive officers at the 2023-05-02 meeting.
“2. To approve, on an advisory basis, the compensation of the Company's named executive officers.”
Cibus, Inc. shareholders approved Election of two Class I directors at the 2023-05-02 meeting.
“1. To elect two Class I directors to our Board of Directors, each to serve a three-year term and until his or her successor has been elected and qualified, or until his or her earlier death, resignation or removal.”
Cibus, Inc. incurred revolving credit of up to $3,000,000 with Cibus Global LLC at interest-free.
“8-K), beginning on March 15, 2023, Calyxt can request, and Cibus Global LLC (“ Cibus ”) has agreed to provide, an unsecured, interest-free revolving line of credit of up to $3,000,000 in cash, which amount may be increased as described in the Merger 8-K (the “ Interim Funding ”). Funds can be drawn by Calyxt in $500,000 increments and may only be used to fund”
Cibus, Inc. reported financial results for the three months ended March 31, 2023.
“On May 1, 2023, Calyxt, Inc. (the “Company”) announced its financial results for the three months ended March 31, 2023.”
Cibus, Inc. incurred revolving credit of $500,000 with Cibus Global LLC at interest-free.
“(“ Calyxt ”) on January 17, 2023 (the “ Merger 8-K ”), pursuant to the terms of the Merger Agreement (as defined in the Merger 8-K), beginning on March 15, 2023, Calyxt can request, and Cibus Global LLC (“ Cibus ”) has agreed to provide, an unsecured, interest-free revolving line of credit of up to $3,000,000 in cash, which amount may be increased as described in the Merger 8-K (the “ Interim Funding ”).”
Cibus, Inc. amended First Amendment to the Merger Agreement with Cibus Global, LLC (effective 2023-04-14).
“On April 14, 2023, the Calyxt and Cibus entered into a First Amendment to the Merger Agreement to correct a scrivener’s error in the definition of “Public Company Class A Common Stock” in Article IX of the Merger Agreement (“ Amendment No. 1 ”).”
Cibus, Inc. incurred revolving credit of up to $3,000,000 with Cibus Global LLC at interest-free.
“an unsecured, interest-free revolving line of credit of up to $3,000,000 in cash”
Cibus, Inc. reported financial results for the fourth quarter ended December 31, 2022.
“Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its fourth quarter ended December 31, 2022.”
Cibus, Inc. reported financial results for the year ended December 31, 2022.
“On March 2, 2023, Calyxt, Inc. (the “Company”) announced its financial results for the year ended December 31, 2022.”
Cibus, Inc. entered into Agreement and Plan of Merger with Cibus Global LLC, New Ventures I Holdings, LLC, BCGF CB Holdings LLC, BCGFCP CB HOLDINGS LLC, BCGFK CB Holdings LLC, FSBCGF CB Holdings LLC, PYLBCG CB Holdings LLC, FSGRWCO CB Holdings LLC, GROWTHCO CB Holdings LLC, GRTHCOCP CB Holdings LLC, GRWTHCOK CB Holdings LLC (effective 2023-01-13).
“On January 13, 2023, Calyxt, Inc., a Delaware corporation (“ Calyxt ”), and Calypso Merger Subsidiary, LLC, a Delaware limited liability company and wholly-owned subsidiary of Calyxt (“ Merger Subsidiary ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ,” and the transactions contemplated thereby, the “ Transactions ”) with Cibus Global LLC, a Delaware limited liability company (“ Cibus ”); New Ventures I Holdings, LLC, a Delaware limited liability company (“ Blocker 1 ”); BCGF CB Holdings LLC, a Delaware limited liability company (“ Blocker 2 ”); BCGFCP CB HOLDINGS LLC, a Delaware limited liability company (“ Blocker 3 ”); BCGFK CB Holdings LLC, a Delaware limited liability company (“ Blocker 4 ”); FSBCGF CB Holdings LLC, a Delaware limited liability company (“ Blocker 5 ”); PYLBCG CB Holdings LLC, a Delaware limited liability company (“ Blocker 6 ”); FSGRWCO CB Holdings LLC, a Delaware limited liability company (“ Blocker 7 ”); GROWTHCO CB Holdings LLC, a Delaw”
Michael A. Carr was appointed as Director at Cibus, Inc..
“the Company’s Board also approved an increase in the number of directors on the Board from seven to eight and appointed Mr. Carr, effective as of the Start Date, to the Board of Directors to fill the newly created directorship.”
Michael A. Carr was appointed as President and Chief Executive Officer at Cibus, Inc..
“Michael A. Carr will join the Company, effective July 27, 2021 (the “Start Date”), as its President and Chief Executive Officer.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.